WP
ARNA

WealthPLAN Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

WealthPLAN Partners’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$190 Buy
+30
New +$612 ﹤0.01% 1622
2015
Q2 		$0 Hold
10
– – ﹤0.01% 524
2015
Q1 		$0 Buy
+10
New +$465 ﹤0.01% 543

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

WealthPLAN Partners's ARNA Position: Q4 2015 in Review

WealthPLAN Partners opened a new position in Arena Pharmaceuticals Inc (ARNA) in Q4 2015: 30 shares worth $190. The stake represents ﹤0.01% of the portfolio and ranks #1622 among its holdings. This is a return to the name: WealthPLAN Partners previously reported a position in ARNA as recently as Q2 2015.

WealthPLAN Partners first reported a position in ARNA in Q1 2015 and has held it in 3 quarters since. 121 funds tracked by Wall St. Rank hold ARNA as of Q4 2015.

  • WealthPLAN Partners held 30 shares of Arena Pharmaceuticals Inc worth $190 as of Q4 2015.
  • Arena Pharmaceuticals Inc was a new WealthPLAN Partners position in Q4 2015.
  • Arena Pharmaceuticals Inc made up ﹤0.01% of WealthPLAN Partners's portfolio in Q4 2015, its #1622 holding.
  • WealthPLAN Partners first reported a position in Arena Pharmaceuticals Inc in Q1 2015 and has held it in 3 quarters since.
  • 121 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2015.

Based on WealthPLAN Partners's 13F filing for Q4 2015, filed 24 Mar 2016.